Biblio

Author Title Type [ Year(Asc)]
Filters: Author is He, Jingsong  [Clear All Filters]
2024
Jin D, Chen H, He J, Li Y, Zheng G, Yang Y, Zhao Y, Le J, Shu W, He D, et al. Impact of AML1/ETO Fusion on the Efficacy of Venetoclax Plus Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia. Target Oncol. 2024.
Jiang B, Zhao Y, Luo Y, Yu J, Chen Y, Ye B, Fu H, Lai X, Liu L, Ye Y, et al. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring Rearrangement and Its Prognostic Factors. Cell Transplant. 2024;33:9636897231225821.
2023
Zhao Y, Huang X, Zhang YJ, He D, He J, Zhang E, Chen M, Liu Q, Chen J, Cai Z. Assessing cell chimerism in an acute graft-versus-host disease model established in TLR4 knockout mice. Cir Cir. 2023;91(5):601-614.
Yang T, Jiang B, Luo Y, Zhao Y, Ouyang G, Yu J, Lan J, Lu Y, Lai X, Ye B, et al. Comparison of the prognostic predictive value of Molecular International Prognostic Scoring System and Revised International Prognostic Scoring System in patients undergoing allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms. Am J Hematol. 2023.
Jin D, He J, Wu W, Han X, Le J, Shu W, Fu J, Kong H, Wang G, Zhou X, et al. Outcomes of COVID-19 in multiple myeloma patients treated with daratumumab. Cancer Sci. 2023.
2022
He D, Zhu C, Guo X, Huang X, Han X, Zheng G, Zhao Y, Yang Y, Wu W, Ge J, et al. The efficacy of residual plerixafor for second-day stem cell mobilization in multiple myeloma patients. Transfus Apher Sci. 2022:103618.
2020
Li X, Guo X, Zhu Y, Wei G, Zhang Y, Li X, Xu H, Cui J, Wu W, He J, et al. Single cell transcriptomic analysis reveals BCMA CAR-T cell dynamics in a patient with refractory primary plasma cell leukemia. Mol Ther. 2020.